Author

Ksenia Blinova

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Advances in New Approach Methodologies at FDA's Division of Applied Regulatory Science

In silico and in vitro NAMs including quantitative systems pharmacology (QSP) modeling for opioid overdose scenarios, (quantitative) structure–activity relationship ((Q)SAR) modeling for toxicity prediction and drug–drug interaction assessment, and multi‐omics approaches for pharmacodynamic biomarker discovery are desc...

Ksenia Blinova, Kimberly Chiu, Anik Chaturbedi et al. · Clinical pharmacology and th... · 0 citations

Review Open access Jul 2026

Intranasal drug delivery to the brain for neurodegenerative diseases: Current efforts and challenges in delivery platforms and modeling

Neurodegenerative diseases, such as Parkinson’s disease (PD) and Alzheimer’s disease (AD), globally pose a significant challenge with an aging population. Despite the presence of various therapeutic agents, AD and PD treatments with small molecules currently only address the symptoms; certain biologic agents for AD hav...

Katherine Y. Bang, Ross L. Walenga, Steven Chopski et al. · Advanced Drug Delivery Revie... · 0 citations